Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 12,125 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non-interventional. Clear all

Conditions: Autism Spectrum Disorder
Interventions: Continuous Theta Burst Stimulation; Device
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 11 Years to 25 Years
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Continuous glucose monitor (CGM); Device
Lead sponsor: Diabetes Solutions International; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Greenfield, Massachusetts

Conditions: Medication Adherence, Asthma in Children
Interventions: Nominal Financial Incentives, Daily Adherence Reminders/Adherence Performance Feedback; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 5 Years to 12 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cancer, Pain
Interventions: Facebook, ACCESS; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 3
States / cities: Columbia, Missouri • Kansas City, Missouri • St Louis, Missouri

Conditions: Asthma, Smoking Cessation
Interventions: PAM, PAM-Enhanced/Asthma Counseling Phone Calls, Follow-Up Phone Calls - Child Wellness Topic; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older
Enrollment: 573 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 5
States / cities: Fall River, Massachusetts • Pawtucket, Rhode Island • Providence, Rhode Island + 1 more

Conditions: Epstein-Barr Virus Infections, Cytomegalovirus Infections, Adenovirus, BK Virus Infection
Interventions: Rapidly generated virus specific T (R-MVST) cells; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Effect of tDCS on Memory in Older and Younger Adults
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 271 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Preterm Labor, Preterm Birth
Interventions: Multimodal intervention strategy; Other
Lead sponsor: Sera Prognostics, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 6,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 18
States / cities: San Diego, California • New Haven, Connecticut • Newark, Delaware + 15 more

Conditions: Behavior
Interventions: smoking abstinence, smoking satiety; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 55 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
Interventions: cyclophosphamide, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy; Drug · Procedure · Radiation
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Achalasia
Interventions: Peroral Endoscopic Myotomy a less invasive treatment for Achalasia; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Heart Failure Congenital, Single-ventricle
Interventions: Cardiac rehabilitation, Usual care; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Stanford, California • Nashville, Tennessee

Conditions: Prostate Cancer
Interventions: Ixabepilone, Prostatectomy; Drug · Procedure
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Heart Arrest, Implantable Defibrillator User, Physical Activity
Interventions: E-ICD Intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pancreatitis
Interventions: Data Management and Monitoring; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2,345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pregnancy, Labor, Induced
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 10 Years and older · Female only
Enrollment: 2,546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 2 Diabetes
Interventions: Continuous glucose monitor; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Acute Myocardial Infarction (AMI), Coronary Occlusion, Acute Coronary Syndrome
Interventions: Guardian System; Device
Lead sponsor: Angel Medical Systems; Industry
Eligibility: 21 Years and older
Enrollment: 1,020 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 95
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 85 more

Conditions: Kidney Cancer, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Interventions: Doppler Ultrasound, SIEMENS S3000 and Verasonics Vantage 256, Standard-of-care Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) tyrosine kinase inhibitor (TKI) plus immune checkpoint inhibitor (ICI), Standard-of-care non-immune checkpoint inhibitor (ICI) such as single-agent VEGFR2 TKI; Diagnostic Test · Device · Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Head and Neck Cancer
Interventions: EF5, bioluminescence, flow cytometry, immunohistochemistry staining method, biopsy; Drug · Other · Procedure
Lead sponsor: David M. Brizel, MD; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Prosthetic Joint Infection, Debridement With Prosthesis Retention, Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Suture
Interventions: VICRYL™ Plus (Coated VICRYL™ Plus Antibacterial), Polydioxanone (PDS™ II ) Sterile Synthetic Absorbable Surgical Suture-Monofilament; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 89 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Hypertension (HTN), Obesity & Overweight
Interventions: Mind Your Heart, DASH Diet Education; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Breast Cancer
Interventions: Cisplatin, Radiation Therapy, Mastectomy; Drug · Radiation · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertension, Prehypertension
Interventions: MB-BP, Enhanced Usual Care Control; Behavioral · Other
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations

The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial

ACCESS (Access for Cancer Caregivers for Education and Support for Shared Decision Making)

Sustaining Smoking Cessation in Smokers With Kids With Asthma

R-MVST Cells for Treatment of Viral Infections

Effect of Noninvasive Electrical Brain Stimulation on Memory at Different Times of Day in Younger and Older Adults

Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs

Effects of Smoking State on Decision Making

Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer

The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia

REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Effectiveness of Exercise After an ICD

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies

Labor Induction With Oral Versus Vaginal Misoprostol

Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring

AngelMed for Early Recognition and Treatment of STEMI

Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)

EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer

Antibiotic-coated Braided Suture Study

University of Georgia Mind Your Heart Pilot Study

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT